Selectively replicating viral vectors
- 22 November 2002
- journal article
- review article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 9 (12) , 987-1000
- https://doi.org/10.1038/sj.cgt.7700547
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinomaCancer Gene Therapy, 2002
- Toward a New Generation of Conditionally Replicating Adenoviruses: Pairing Tumor Selectivity with Maximal OncolysisHuman Gene Therapy, 2002
- Variation in Adenovirus Receptor Expression and Adenovirus Vector-Mediated Transgene Expression at Defined Stages of the Cell CycleMolecular Therapy, 2001
- Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regressionGene Therapy, 2000
- Langerhans Cells Migrate to Local Lymph Nodes Following Cutaneous Infection with an ArbovirusJournal of Investigative Dermatology, 2000
- An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapyNature Biotechnology, 1998
- Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukinsGene Therapy, 1998
- Replicating vectors for gene therapy of cancer: risks, limitations and prospectsEuropean Journal Of Cancer, 1994
- p53 and DNA polymerase α compete for binding to SV40 T antigenNature, 1987
- REGRESSION OF HODGKIN'S DISEASE AFTER MEASLESThe Lancet, 1981